Mevion Medical Systems is set to launch a new Hyperscan system, claimed to be the world’s first proton therapy solution that can deliver pencil beam scanning at high-speed.
The Hyperscan technology is built on the MEVION S250 proton therapy platform, which has been in operation since December 2013.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The system offers rapid volumetric and layer rescanning, streamlined image-based clinical workflow, sub-millimeter position tracking, and beam gating connectivity.
By using a sharp beam of radiation, the patented technology of Hyperscan allows precise delivery of radiation, with the tumour being volumetrically scanned in few seconds, said Mevion.
The existing pencil beam delivery systems are sensitive to motion, while Hyperscan’s fast beam delivery is said to be less sensitive to patient and tumor motions, which enables better treatment.
Mevion Medical Systems president and CEO Joseph Jachinowski said: "Hyperscan enables treatment with fine precision at tremendous speed and with uncompromised beam quality"
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"This new technological advance will help providers deliver the best possible cancer care to the patients who need it most."
The company will debut the Hyperscan system at the 56th annual meeting of the American Society for Radiation Oncology, which will be held at San Francisco, US, between 14-16 September.
The US Food and Drug Administration (FDA) has not yet approved Hyperscan for clinical use.
Image: Hyperscan debuts at the 56th annual meeting of the American Society for Radiation Oncology in San Francisco. Photo: courtesy of Business Wire.
